These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1763143)

  • 1. Apomorphine effects on brain metabolism in neuroleptic-naive schizophrenic patients.
    Cleghorn JM; Szechtman H; Garnett ES; Nahmias C; Brown GM; Kaplan RD; Szechtman B; Franco S
    Psychiatry Res; 1991 Oct; 40(2):135-53. PubMed ID: 1763143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional brain metabolism during auditory hallucinations in chronic schizophrenia.
    Cleghorn JM; Garnett ES; Nahmias C; Brown GM; Kaplan RD; Szechtman H; Szechtman B; Franco S; Dermer SW; Cook P
    Br J Psychiatry; 1990 Oct; 157():562-70. PubMed ID: 2131139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered frontostriatal relationship in unmedicated schizophrenic patients.
    Biver F; Goldman S; Luxen A; Delvenne V; De Maertelaer V; De La Fuente J; Mendlewicz J; Lotstra F
    Psychiatry Res; 1995 Sep; 61(3):161-71. PubMed ID: 8545500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cortical-striatal-thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients.
    Siegel BV; Buchsbaum MS; Bunney WE; Gottschalk LA; Haier RJ; Lohr JB; Lottenberg S; Najafi A; Nuechterlein KH; Potkin SG
    Am J Psychiatry; 1993 Sep; 150(9):1325-36. PubMed ID: 8352343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of cortical activity in schizophrenia.
    Schroeder J; Buchsbaum MS; Siegel BV; Geider FJ; Haier RJ; Lohr J; Wu J; Potkin SG
    Psychol Med; 1994 Nov; 24(4):947-55. PubMed ID: 7892362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward a brain map of auditory hallucinations.
    Cleghorn JM; Franco S; Szechtman B; Kaplan RD; Szechtman H; Brown GM; Nahmias C; Garnett ES
    Am J Psychiatry; 1992 Aug; 149(8):1062-9. PubMed ID: 1353314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional cerebral glucose metabolism in major depressive disorder.
    Hurwitz TA; Clark C; Murphy E; Klonoff H; Martin WR; Pate BD
    Can J Psychiatry; 1990 Nov; 35(8):684-8. PubMed ID: 2282619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol.
    Holcomb HH; Cascella NG; Thaker GK; Medoff DR; Dannals RF; Tamminga CA
    Am J Psychiatry; 1996 Jan; 153(1):41-9. PubMed ID: 8540590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlational patterns of cerebral glucose metabolism in never-medicated schizophrenics.
    Katz M; Buchsbaum MS; Siegel BV; Wu J; Haier RJ; Bunney WE
    Neuropsychobiology; 1996; 33(1):1-11. PubMed ID: 8821368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroleptic effects on regional brain metabolism in first episode schizophrenics.
    Cleghorn JM; Szechtman H; Garnett ES; Brown GM; Nahmias C; Szechtman B; Kaplan R; Franco S
    Schizophr Res; 1991 Oct; 5(3):208-9. PubMed ID: 1684720
    [No Abstract]   [Full Text] [Related]  

  • 11. Stability of resting deoxyglucose metabolic values in PET studies of schizophrenia.
    Bartlett EJ; Barouche F; Brodie JD; Wolkin A; Angrist B; Rotrosen J; Wolf AP
    Psychiatry Res; 1991 May; 40(1):11-20. PubMed ID: 1946838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional cerebral glucose metabolism and attention in adults with a history of childhood autism.
    Siegel BV; Asarnow R; Tanguay P; Call JD; Abel L; Ho A; Lott I; Buchsbaum MS
    J Neuropsychiatry Clin Neurosci; 1992; 4(4):406-14. PubMed ID: 1422167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased frontal and reduced parietal glucose metabolism in acute untreated schizophrenia.
    Cleghorn JM; Garnett ES; Nahmias C; Firnau G; Brown GM; Kaplan R; Szechtman H; Szechtman B
    Psychiatry Res; 1989 May; 28(2):119-33. PubMed ID: 2787515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three clinical syndromes of schizophrenia in untreated subjects: relation to brain glucose activity measured by positron emission tomography (PET).
    Kaplan RD; Szechtman H; Franco S; Szechtman B; Nahmias C; Garnett ES; List S; Cleghorn JM
    Schizophr Res; 1993 Dec; 11(1):47-54. PubMed ID: 8297804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased temporal lobe glucose use in chronic schizophrenic patients.
    DeLisi LE; Buchsbaum MS; Holcomb HH; Langston KC; King AC; Kessler R; Pickar D; Carpenter WT; Morihisa JM; Margolin R
    Biol Psychiatry; 1989 Apr; 25(7):835-51. PubMed ID: 2785820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A PET study of the pathophysiology of negative symptoms in schizophrenia. Positron emission tomography.
    Potkin SG; Alva G; Fleming K; Anand R; Keator D; Carreon D; Doo M; Jin Y; Wu JC; Fallon JH
    Am J Psychiatry; 2002 Feb; 159(2):227-37. PubMed ID: 11823264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The estimated density of D2 striatal receptors in schizophrenia. A study with positron emission tomography and 76Br-bromolisuride.
    Martinot JL; Paillère-Martinot ML; Loc'h C; Hardy P; Poirier MF; Mazoyer B; Beaufils B; Mazière B; Allilaire JF; Syrota A
    Br J Psychiatry; 1991 Mar; 158():346-50. PubMed ID: 1827999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kraepelinian and non-Kraepelinian schizophrenia subgroup differences in cerebral metabolic rate.
    Buchsbaum MS; Shihabuddin L; Hazlett EA; Schröder J; Haznedar MM; Powchik P; Spiegel-Cohen J; Wei T; Singer MB; Davis KL
    Schizophr Res; 2002 May; 55(1-2):25-40. PubMed ID: 11955961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of attention on frontal distribution of delta activity and cerebral metabolic rate in schizophrenia.
    Guich SM; Buchsbaum MS; Burgwald L; Wu J; Haier R; Asarnow R; Nuechterlein K; Potkin S
    Schizophr Res; 1989; 2(6):439-48. PubMed ID: 2487185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute d-amphetamine challenge in schizophrenia: effects on cerebral glucose utilization and clinical symptomatology.
    Wolkin A; Sanfilipo M; Angrist B; Duncan E; Wieland S; Wolf AP; Brodie JD; Cooper TB; Laska E; Rotrosen JP
    Biol Psychiatry; 1994 Sep; 36(5):317-25. PubMed ID: 7993958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.